Glucocorticoids suppress macrophage migration inhibitory factor (MIF) expression in a cell-type-specific manner

Journal of Molecular Endocrinology

Volumn 34, Issue 2, 2005, Pages 583-595

  Alourfi, Z ^a   Donn, R P ^a   Stevens, A ^a   Berry, A ^a   McMaster, A ^a   Ray, David W ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; DEXAMETHASONE; GLUCOCORTICOID; MACROPHAGE MIGRATION INHIBITION FACTOR; MESSENGER RNA;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL TYPE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENETIC POLYMORPHISM; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN SECRETION; QUANTITATIVE ANALYSIS; RADIOIMMUNOASSAY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; T LYMPHOBLAST;

ANIMALS; CELL LINE; CYCLIC AMP; GENE EXPRESSION REGULATION; GLUCOCORTICOIDS; HUMANS; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); RATS; RECEPTORS, GLUCOCORTICOID; RNA, MESSENGER; TETRADECANOYLPHORBOL ACETATE;

EID: 17844378996     PISSN: 09525041     EISSN: None     Source Type: Journal    
DOI: 10.1677/jme.1.01647     Document Type: Article

References (41)

1. Anonymous 1996 Heat inactivation - are you wasting your time? Art to Science (HyClone Newsletter) 15 1-5.
2. Baniahmad C, Muller M, Altschmied J & Renkawitz R 1991 Co-operative binding of the glucocorticoid receptor DNA binding domain is one of at least two mechanisms for synergism. Journal of Molecular Biology 222 155-165.
3. Barnes PJ 1998 Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clinical Science 94 557-572.
4. Barton A, Lamb R, Symmons D, Silman A, Thomson W, Worthington J & Donn R 2003 Macrophage migration inhibitory factor (MIF) gene polymorphism is associated with susceptibility to but not severity of inflammatory polyarthritis. Genes and Immunity 4 487-491.
5. Baugh JA, Chitnis S, Donnelly SC, Monteiro J, Lin X, Plant BJ, Wolfe F, Gregersen PK & Bucala R 2002 A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis. Genes and Immunity 3 170-176.
6. Bloom BR & Bennett B 1966 Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science 153 80-82.
7. Boutillier AL, Sassone-Corsi P & Loeffler JP 1991 The protooncogene c-fos is induced by corticotropin-releasing factor and stimulates proopiomelanocortin gene transcription in pituitary cells. Molecular Endocrinology 5 1301-1310.
8. Bozza M, Satoskar AR, Lin G, Lu B, Humbles AA, Gerard C & David JR 1999 Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis. Journal of Experimental Medicine 189 341-346.
9. Brunet CL, Gunby RH, Benson RS, Hickman JA, Watson AJ & Brady G 1998 Commitment to cell death measured by loss of clonogenicity is separable from the appearance of apoptotic markers. Cell Death and Differentiation 5 107-115.
10. Calandra T, Bernhagen J, Metz CN, Spiegel LA, Bacher M, Donnelly T, Cerami A & Bucala R 1995 MIF as a glucocorticoid-induced modulator of cytokine production. Nature 377 68-71.
11. David JR 1966 Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. PNAS 56 72-77.
12. De Benedetti F, Meazza C, Vivarelli M, Rossi F, Pistorio A, Lamb R, Lunt M, Thomson W, Ravelli A, Donn R & Martini A 2003 Functional and prognostic relevance of the -173 polymorphism of the macrophage migration inhibitory factor gene in systemic-onset juvenile idiopathic arthritis. Arthritis and Rheumatism 48 1398-1407.
13. Diamond MI, Miner JN, Yoshinaga SK & Yamamoto KR 1990 Transcription factor interactions: selectors of positive or negative regulation from a single DNA element. Science 249 1266-1272.
14. Donn R, Alourfi Z, De Benedetti F, Meazza C, Zeggini E, Lunt M, Stevens A, Shelley E, Lamb R, Ollier WE, Thomson W & Ray D 2002 Mutation screening of the macrophage migration inhibitory factor gene: positive association of a functional polymorphism of macrophage migration inhibitory factor with juvenile idiopathic arthritis. Arthritis and Rheumatism 46 2402-2409.
15. Donn RP & Ray DW 2004 Macrophage migration inhibitory factor (MIF): molecular, cellular and genetic aspects of a key neuroendocrine molecule. Journal of Endocrinology 182 1-9.
16. Donn RP, Shelley E, Ollier WE & Thomson W 2001 A novel 5′-flanking region polymorphism of macrophage migration inhibitory factor is associated with systemic-onset juvenile idiopathic arthritis. Arthritis and Rheumatism 44 1782-1785.
17. Donn RP, Alourfi Z, Zeggini E, Lamb R, Jury F, Lunt M, BPRG Study Group, Meazza C, De Benedetti F, Thomson W & Ray D 2004 A functional promoter haplotype of macrophage migration inhibitory factor (MIF) is linked and associated with juvenile idiopathic arthritis. Arthritis and Rheumatism 50 1604-1610.
18. Fingerle-Rowson G, Koch P, Bikoff R, Lin X, Metz CN, Dhabhar FS, Meinhardt A & Bucala R 2003 Regulation of macrophage migration inhibitory factor expression by glucocorticoids in vivo. American Journal of Pathology 162 47-56.
19. Gregersen PK & Bucala R 2003 Macrophage migration inhibitory factor, MIF alleles, and the genetics of inflammatory disorders: incorporating disease outcome into the definition of phenotype. Arthritis and Rheumatism 48 1171-1176.
20. Huynh TT, Ray DW, Brogan IJ, Stevens A, Davis JR, White A & White A 2002 Failure of steroid regulation of the MMTV promoter in a small cell lung cancer cell line is caused by a DNA sequence flanking the glucocorticoid response element. Journal of Endocrinology 172 295-302.
21. Leech M, Metz C, Santos L, Peng T, Holdsworth SR, Bucala R & Morand EF 1998 Involvement of macrophage migration inhibitory factor in the evolution of rat adjuvant arthritis. Arthritis and Rheumatism 41 910-917.
22. Leech M, Lacey D, Xue JR, Santos L, Hutchinson P, Wolvetang E, David JR, Bucala R & Morand EF 2003 Regulation of p53 by macrophage migration inhibitory factor in inflammatory arthritis. Arthritis and Rheumatism 48 1881-1889.
23. Lue H, Kleemann R, Calandra T, Roger T & Bernhagen J 2002 Macrophage migration inhibitory factor (MIF): mechanisms of action and role in disease. Microbes and Infection 4 449-460.
24. Meyuhas O 2000 Synthesis of the translational apparatus is regulated at the translational level. European Journal of Biochemistry 267 6321-6330.
25. Mikulowska A, Metz CN, Bucala R & Holmdahl R 1997 Macrophage migration inhibitory factor is involved in the pathogenesis of collagen type II-induced arthritis in mice. Journal of Immunology 158 5514-5517.
26. Muller M, Baniahmad C, Kaltschmidt C & Renkawitz R 1991 Multiple domains of the glucocorticoid receptor involved in synergism with the CACCC box factor(s). Molecular Endocrinology 5 1498-1503.
27. Neeck G, Renkawitz R & Eggert M 2002 Molecular aspects of glucocorticoid hormone action in rheumatoid arthritis. Cytokines, Cellular and Molecular Therapy 7 61-69.
28. Nishihira J 1998 Novel pathophysiological aspects of macrophage migration inhibitory factor (review). International Journal of Molecular Medicine 2 17-28.
29. Nissen RM & Yamamoto KR 2000 The glucocorticoid receptor inhibits NFkappaB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain. Genes and Development 14 2314-2329.
30. Paralkar V & Wistow G 1994 Cloning the human gene for macrophage migration inhibitory factor (MIF). Genomics 19 48-51.
31. Petrovsky N, Socha L, Silva D, Grossman AB, Metz C & Bucala R 2003 Macrophage migration inhibitory factor exhibits a pronounced circadian rhythm relevant to its role as a glucocorticoid counter-regulator. Immunology and Cell Biology 81 137-143.
32. Ray DW, Suen CS, Brass A, Soden J & White A 1999 Structure/function of the human glucccorticoid receptor: tyrosine 735 is important for transactivation. Molecular Endocrinology 13 1855-1863.
33. Rogatsky I, Luecke HF, Leitman DC & Yamamoto KR 2002 Alternate surfaces of transcriptional coregulator GRIP1 function in different glucccorticoid receptor activation and repression contexts. PNAS 99 16701-16706.
34. Rogatsky I, Wang JC, Derynck MK, Nonaka DF, Khodabakhsh DB, Haqq CM, Darimont BD, Garabedian MJ & Yamamoto KR 2003 Target-specific utilization of transcriptional regulatory surfaces by the glucocorticoid receptor. PNAS 100 13845-13850.
35. Santos L, Hall P, Metz C, Bucala R & Morand EF 2001 Role of macrophage migration inhibitory factor (MIF) in murine antigen-induced arthritis: interaction with glucocorticoids. Clinical and Experimental Immunology 123 309-314.
36. Soden J, Stevens A & Ray DW 2002 Genetic engineering of the glucocorticoid receptor by fusion with the herpes viral protein VP22 causes selective loss of transactivation. Journal of Endocrinology 172 615-625.
37. Stevens A, Ray D, Alansari A, Hajeer A, Thomson W, Donn R, Ollier WE, Worthington J & Davis JR 2001 Characterization of a prolactin gene polymorphism and its associations with systemic lupus erythematosus. Arthritis and Rheumatism 44 2358-2366.
38. Stevens A, Garside H, Berry A, Waters C, White A & Ray DW 2003 Dissociation of SRCI and NCOR recruitment to the human glucocorticoid receptor by modification of the ligand-receptor interface. Molecular Endocrinology 17 845-849.
39. Stevens A, Ray DW, Zeggini E, John S, Richards HL, Griffiths CE & Donn R 2004 Glucocorticoid sensitivity is determined by a specific glucocorticoid receptor haplotype. Journal of Clinical Endocrinology and Metabolism 89 892-897.
40. Waeber G, Thompson N, Chautard T, Steinmann M, Nicod P, Pralong FP, Calandra T & Gaillard RC 1998 Transcriptional activation of the macrophage migration-inhibitory factor gene by the corticotropin-releasing factor is mediated by the cyclic adenosine 3′,5′-monophosphate responsive element-binding protein CREB in pituitary cells. Molecular Endocrinology 12 698-705.
41. Webster JC, Huber RM, Hanson RL, Collier PM, Haws TF, Mills JK, Burn TC & Allegretto EA 2002 Dexamethasone and tumor necrosis factor-alpha act together to induce the cellular inhibitor of apoptosis-2 gene and prevent apoptosis in a variety of cell types. Endocrinology 143 3866-3874.